Kristian Borbos
Förmögenhet: 184 745 $ per 2026-07-31
Förmögenhet: 184 745 $ per 2026-07-31
Kristian Borbos is currently Deputy Director at Ascelia Incentive AB and Chief Financial Officer at Gubra A since 2022.
Former roles include Chief Financial Officer at Ascelia Pharma AB from 2017 to 2022, Manager-Business Finance at Novozymes A from 2016 to 2017, and Lead Manager-Investor Relations at Ørsted A and Ørsted AB from 2009 to 2016.
Education includes graduate studies at the University of Lund.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
GUBRA A/S 0,02 % | 2025-12-31 | 3 103 ( 0,02 % ) | 184 745 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| GUBRA A/S | Finansdirektör/CFO | 2022-08-01 |
Ascelia Incentive AB | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
| ASCELIA PHARMA AB | Finansdirektör/CFO | 2022-09-01 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Företagsledare/Principal | 2017-09-01 |
| ORSTED A/S | Offentlig kommunikationskontakt | 2016-07-01 |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Investor Relations Kontakt | 2016-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 7 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Ørsted A/S
Ørsted A/S Electric UtilitiesUtilities Develops, constructs and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities and bioenergy plants | Utilities |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ørsted AB
Ørsted AB Gas DistributorsUtilities Produces and distributes natural gas and oil products | Utilities |
Ascelia Pharma AB
Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Gubra A/S
Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
Ascelia Incentive AB |
Välj din utgåva
All finansiell information anpassad till den nationella nivån